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Plectin is one of the largest and most versatile cyto-
linker proteins known. In basal keratinocytes it links
the intermediate ®lament network to cell mem-
brane-associated hemidesmosomes. Several muta-
tions in its gene have been identi®ed that lead to the
recessive disease epidermolysis bullosa with muscular
dystrophy. We report here a mutation that leads to a
dominant form of the disease, epidermolysis bullosa
simplex Ogna. We found that the epidermolysis bul-
losa simplex Ogna phenotype is due to a site-speci®c
missense mutation within plectin's rod domain.
Further, we show that epidermolysis bullosa simplex
Ogna is not restricted to a single Norwegian kindred
as previously believed. A German family with the
phenotypic hallmarks of epidermolysis bullosa sim-
plex Ogna was found to carry an identical de novo
mutation. These two mutations arose about 200 y
apart in time. Consistent with the absence of muscu-
lar symptoms in these patients, muscle biopsies from
several epidermolysis bullosa simplex Ogna members
of the Norwegian kindred showed normal staining
patterns using antibodies to plectin. Skin changes in
epidermolysis bullosa simplex Ogna patients are
documented on the ultrastructural level. Key words:
cytokeratins/cytolinkers/missense mutations/plakins/PLEC1
gene. J Invest Dermatol 118:87±93, 2002
E
pidermolysis bullosa simplex (EBS) is a group of
dominantly inherited intraepidermally blistering skin
disorders. A new type of EBS was identi®ed in 1970
because of its generalized skin fragility (Gedde-Dahl,
1971). This Ogna type (EBS-O, OMIM 131950) is
genetically linked to the GPT isozyme polymorphism (Olaisen and
Gedde-Dahl, 1973), which is assigned to chromosome 8q24 (Astrin
et al, 1982; Pocha et al, 1988). The other EBS types are known to
be caused by mutations in the genes for the basal cell keratins 5 and
14, residing in the keratin clusters II and I on chromosomes 12 and
17 (Coulombe et al, 1991; Lane et al, 1992; Fuchs, 1999). Defects in
proteins other than keratins have only recently been found to cause
certain types of EBS (see below).
Hemidesmosomes (HD) are junctional attachment complexes
mediating adhesion of the basal keratinocytes to the underlying
basal lamina (Borradori and Sonnenberg, 1999). Ultrastructurally,
HD consist of an intracellular attachment plate on the cytoplasmic
face of the plasma membrane and an extracellular subbasal dense
plate in the upper space of the lamina rara (lamina lucida), traversed
by ®ne anchoring ®laments, together forming highly speci®c
attachment devices that link basal cells and their cytoskeleton to the
basal lamina (Anton-Lamprecht, 1992). HD comprise various
intracellular, transmembranous, and extracellular proteins: bullous
pemphigoid antigen 1 and plectin are intracellular plaque proteins,
a6b4 integrin and bullous pemphigoid antigen 2 are transmem-
branous with variably large extracellular collagenous domains, and
laminin-5 is entirely extracellular and located in the deep lamina
rara (Burgeson and Christiano, 1997).
Plectin, one of the plakin/cytolinker protein family members
(Ruhrberg and Watt, 1997; Wiche, 1998), acts as a general
crosslinking element of intermediate ®laments (Wiche et al, 1982;
Wiche, 1998). In epidermal cells it links keratins to the intracellular
parts of desmosomes and HD (Wiche et al, 1983; AndraÈ et al, 1997;
Rezniczek et al, 1998). Plectin also binds desmin to the Z-line
structures and dense plaques of striated and smooth muscle cells
(Wiche et al, 1983; Reipert et al, 1999). The cytokeratin binding
site of plectin is contained in a sequence of ~50 amino acids within
the ®fth carboxy-terminal globular repeat (Nikolic et al, 1996). The
C-terminal domain interacts also with the long intracellular domain
of the transmembranous integrin subunit protein b4 and integrin
b4 binding occurs also via the N-terminal domain of the molecule
(Rezniczek et al, 1998; Geerts et al, 1999). In addition, plectin binds
to actin and micro®laments (Seifert et al, 1992; AndraÈ et al, 1998).
Plectin was ®rst cloned and sequenced from rat (Wiche et al,
1991) and later from man (Liu et al, 1996; McLean et al, 1996) and
mouse (Fuchs et al, 1999). The human gene (PLEC1) was mapped
to chromosome band 8q24 by in situ hybridization and was found
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to comprise 32 coding exons extending over 32 kb (Liu et al,
1996). A number of additional ®rst coding exons, with alternative
splicing into a common exon 2, were identi®ed in rat (Elliott et al,
1997) and mouse (Fuchs et al, 1999). Plectin also exists in a rodless
form where exon 31 is skipped by splicing (Elliott et al, 1997). Lack
of plectin has been shown to result in the recessive human disease
epidermolysis bullosa with muscular dystrophy (EB-MD)
(Chavanas et al, 1996; Gache et al, 1996; McLean et al, 1996;
Pulkkinen et al, 1996; Smith et al, 1996; Uitto et al, 1996; Mellerio
et al, 1997; Dang et al, 1998; Takizawa et al, 1999; Shimizu et al,
1999; Kunz et al, 2000; Rouan et al, 2000; Bauer et al, 2001). The
majority of EB-MD cases identi®ed to date are caused by frameshift
and premature termination codon mutations in the plectin rod
domain.
In this study we report the identi®cation of the plectin mutation
causing EBS-O in the Norwegian family. In addition, we report an
unrelated German family (BED10) with a de novo mutation in the
same position con®rming the causal signi®cance of the mutation for
the Ogna type. We further report that the expression of the
mutation in both the Norwegian and the German family is identical
by immuno¯uorescence and ultrastructure.
MATERIALS AND METHODS
Family material The Norwegian EB25 family (Gedde-Dahl, 1971)
had (by 1991) 121 affected members (Gedde-Dahl, 1991), and the
maximum lod score was +15.2 for the linkage between EBS-O (EBS1)
and GPT (Gedde-Dahl, 1987).
Genomic DNA from 13 individuals, representing 14 8q24 haplotypes
independent in descent, were selected for plectin sequencing. Seven of
these individuals were EBS-O affected members from distantly related
sibships of family EB25. These seven persons were chosen to ensure
differentiation of the EBS1*Ogna-carrying 8q24 haplotype they had in
common, from their seven control haplotypes (see Fig 1). The other six
persons consist of two nonaffected Norwegians (representing four
haplotypes), and four individuals of a Dutch family with EB-MD
(representing only two haplotypes independent in descent).
Because of ultrastructural and clinical similarity with the Ogna
phenotype a German three-generation family (BED10, with a de novo
sporadic EBS case in the second generation and two affected children in
the third generation) identi®ed in 1997 was included in DNA sequen-
cing (BED10-1, -2, -4, -7, -8). Nine members of this family (Fig 2a)
were sampled for DNA haplotyping. The ®rst affected member of this
family and her parents were additionally typed for six ``forensic''
microsatellite DNA markers (Olaisen and Stenersen, 1996).
DNA sequencing Plectin sequences deposited in GenBank (accession
numbers U63610, Z54367, X59601, U53204, and NM_000445) were
used to design polymerase chain reaction (PCR) primers that will yield
overlapping DNA fragments 4±600 bp long covering the sequence from
the start of exon 2 to the end of exon 32 (Liu et al, 1996), and skipping
only the longest introns.
All PCR primers were designed with m13 tails in order to use m13
primers for sequencing. All forward primers (as de®ned from the 5¢ to 3¢
by the sequences in GenBank) had m13 universal attached whereas all
reverse primers had m13 reverse attached. For most PCR products only
the universal sequencing was performed but in some cases the comple-
mentary strand was sequenced as a control or con®rmation. The PCR
products were puri®ed either using the QIA quick PCR Puri®cation Kit
(Qiagen) or the PCR product pretreatment kit (USB) and subsequently
sequenced using PRISM AmpliTaq FS Dye Primer Cycle Sequencing
Kit (Perkin Elmer) and run on the ABI 377 automatic sequencer.
Sequences were aligned and compared using Sequencher 3.1.1 from
Gene Codes Corporation.
In order to test unrelated normal individuals for the mutation an ABI
Prism SNaPshot ddNTP Primer Extension Kit from Applied Biosystems
was used. This kit extends a primer one nucleotide by adding a single
ddNTP to its 3¢ end. A primer has to be designed with its 3¢ end one
base downstream of the mutation to be assayed. The test was performed
according to the manufacturer's protocol and samples were subsequently
run on an ABI PRISM 377 DNA Sequencer before they were analyzed.
There is a polymorphism 10 bases downstream from the Ogna
mutation so we designed two primers in case the polymorphism should
give rise to problems during the extension step. All samples were tested
with both primers: PLESNP1, CTGGAGGCTGCGAGGCAG;
PLESNP2, CTGGAGGCCGCGAGGCAG.
DNA haplotyping Dinucleotide short tandem repeats were examined
using primer pairs taken from Genethon (Dib et al, 1996) and/or
Figure 1. Selected branches of the
Norwegian EBS-O family EB25 showing
individuals providing blood and tissue
samples for DNA sequencing, electron
microscopy, and immuno¯uorescence of
muscle biopsies.
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Genome Data Bank (http://gdbwww.gdb.org/) on an ABI 377 Perkin
Elmer sequencer. The keratin II cluster was examined by using the
¯anking short tandem repeats D12S1635, D12S1618, and D12S1586,
and the 8q24 haplotypes by the most telomeric marker (D8S373) on the
genetic map (Murray, 1995), depicted in Fig 2(a).
Electron microscopy Skin samples were obtained from two patients
of the Norwegian Ogna family, EB25-16 and EB25-192 (males, see
Fig 1), and from all three affected members of the German family,
BED10-1, BED10-2, and BED10-4 (mother and two children; see
Fig 2a). Skin samples included early blisters and perilesional and intact
skin taken from the volar left forearm and left third ®nger (EB25-192) or
thumb (EB25-16), and from the back of right or left hand (BED10-1,
-2, and -4), respectively. The samples were ®xed in toto at room
temperature with 3% glutaraldehyde in 0.1 mol cacodylate buffer,
pH 7.4, and mailed to Heidelberg, where they were further processed
for electron microscopy including post®xation with osmic acid and
embedding in epoxy resin (glycid ether 100, formerly Epon 812) as
detailed elsewhere (Anton-Lamprecht, 1992). Semithin sections, stained
with methylene blue, were investigated by light microscopy; ultrathin
sections, mounted on Formvar-coated hexagonal copper grids and
treated with uranyl acetate and lead citrate, were investigated by electron
microscopy (Philips EM 400). The evaluation of the ultrastructure of
HD and the dermo-epidermal junction was based both on the
examination of full-length ultrathin sections (about 100 basal cells per
section or more) from at least two or three grids of at least two tissue
blocks of each patient skin sample, and additionally on personal
experience with more than 700 cases of EB patients investigated by
electron microscopy in Heidelberg, and hundreds of non-EB cases
studied over 25 y (controls for HD and ultrastructure of dermo-
epidermal junctions).
Immuno¯uorescence studies ± skin and muscle biopsies Skin
samples from the forearm and the lower back of patient BED10-1
(Fig 2a) were transported to Oslo in sterile medium until freeze-
embedded after 48 h in OCT Tissue Tek 4583 (Miles, Indiana). Biopsies
Figure 2. (a) The German family with a de novo mutation for EBS-O in the plectin gene
(PLEC1). The 8q24 haplotypes reveal that the mutation occurred on the paternal allele. The
mutant is depicted by an arrow. (b) The EB25 and BED10 mutations. The DNA sequence
disclosing C/T heterozygosity in EBS-O patients in both families: (a) Ogna patient EB25-
104, (b) healthy control, (c) affected BED10-4, (d, e) unaffected maternal grandparents
BED10-7 and BED10-8.
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obtained from the ventral or lateral aspect of the quadriceps muscle of
®ve EBS-O members of the EB25 family, as speci®ed in Fig 1, and
from four controls were processed and immunostained as described
elsewhere (Koss-Harnes et al, 1997). Brie¯y, the tissue sections (both skin
and muscle) were incubated with six different monoclonal antibodies
(MoAbs) to rat plectin (clones 7A8, 10F6, and 5B3 were IgG1, 6C6 was
IgG2, and 5C10 IgM; all supernatant ¯uids were diluted 1:2±1:10) for
1 h followed by indocarbocyanine (Cy-3)-labeled goat antimouse heavy
and light chain IgG (1:1000) (Jackson ImmunoResearch Laboratories,
West Grove, PA). The immunostained sections were examined blindly
by two investigators (F.L.J. and D.K.H.) at 4003 magni®cation with a
¯uorescence microscope (model E800; Nikon, Tokyo, Japan).
RESULTS
Identi®cation of the mutation in the Norwegian EB25
pedigree Among the 14 chromosomes sequenced extensively
over the exon 2 to exon 32 region only one base substitution was
present heterozygous in all seven EBS-Ogna individuals, i.e., on
the putative EBS-O haplotype. This C > T transition at genomic
Figure 3. Ultrasound of hemidesmosomes and blister formation in EBS Ogna skin. In intact dermo-epidermal junctions (a±c)
hemidesmosomes (HD) are mostly thin and frequently have fragmented attachment plates (a, c, arrows), but some reveal clear attachment
and inner plates (a). The subbasal dense plates (arrowheads) and anchoring ®laments in the lamina rara, the basal lamina (BL), and anchoring ®brils (AF)
are normal. In contrast, the insertion of basal keratin ®laments (K) into the attachment plates of HD is partly impaired (a±c) or lacking entirely (b), thereby
leading to focal mechanical instability and weakness in the deep cytoplasm of basal keratinocytes. (c) Initial blister formation (asterisk) occurs in the deep
basal cell cytoplasm immediately above the inner plates of HD. (d) The blister ¯oor (open arrows) of a full-blown fresh blister (asterisk) shows HD and cell
debris that are rapidly destroyed so that old blisters may appear ``junctional''. C, collagen ®brils. (a) Patient EB25-192; (b, d) patient BED10-4; (c) patient
BED10-2. Scale bars: (a±c) 0.5 mm; (d) 1 mm.
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position 13775 (GenBank accession number U63610),
corresponding to cDNA position 6328 (GenBank accession
number Z54367; position 6049 in U53204) located in exon 31
(Liu et al, 1996), was detected using ple50 primers (PLE50F,
CGCAACACAAGGCTGACATC; PLE50R, TCCTCCACGT-
TGGCTTTCAG) to amplify the DNA fragment and sequence the
product. This mutation leads to a shift from CGG > TGG in
codon 2110 (Liu et al, 1996; codon 2000 in U53204), resulting in
the substitution of arginine with tryptophan (R2110W) in the
plectin polypeptide. Most other base substitutions observed could
be accounted for by normal polymorphisms (to be published
elsewhere).
As controls 103 clinically normal Norwegians were found to be
homozygous for C at position 13775 (cDNA 6328). Fifty-two of
the control individuals were examined by standard sequencing and
51 by SNaPshot sequencing (results not shown).
Identi®cation of the mutation in the German BED10
family When DNA samples from the BED10 family were
examined with the ple50 primers, the three EBS-affected members
also revealed heterozygosity for the identical C13775T mutation,
whereas the normal grandparents lacked the mutation (Fig 2b).
Tests with six ``forensic'' markers used in routine paternity testing
on individuals 4, 7, and 8 con®rmed the family relationships.
The identi®cation of the same mutation in both families, and in
one of them de novo, con®rms that this mutation is in fact the cause
of the Ogna type of EBS.
Nine members of the German family BED10 (Fig 2a) were also
DNA haplotyped with markers at the keratin cluster II and markers
on 8q24. A keratin 5 mutation was ruled out by independent
segregation. Both affected children, BED10-1 and BED10-2, had
inherited the same maternal grandfather's 8q24 haplotype (Fig 2a).
The 8q24 haplotyping revealed that also the oldest sibling BED10-
5 carries this paternal haplotype harbouring the mutation in the
three affected individuals, but without having the clinical disease
and also being 13775C homozygous as her father. Hence, BED10-
4 at the same time is a de novo mutant for C13775T and for the
dominant clinical disease (Fig 2b).
Results of electron microscopy: diagnosis and
pathomorphogenesis Early blisters and perilesional and intact
skin of two Norwegian Ogna patients, EB25-16 and EB25-192,
and of the three German EBS family BED10 members disclosed
speci®c ultrastructural abnormalities that clearly distinguish this
type of EBS from classical KoÈbner cases (Anton-Lamprecht, 1992;
Gedde-Dahl and Anton-Lamprecht, 1996). This
pathomorphogenetic pattern was ®rst observed in the skin
samples of the two Norwegian Ogna cases. As the same pattern
occurred similarly in all three German EBS patients, these
ultrastructural criteria led to the diagnosis of EBS-O and
prompted the proposal to include this family into the ongoing
series of plectin haplotyping and mutational analysis in Oslo.
Blisters do not start via cytolysis of subnuclear central portions of
the basal cell cytoplasm as in EBS KoÈbner and EBS Weber±
Cockayne (Haneke and Anton-Lamprecht, 1982; Anton-
Lamprecht, 1992) but originate in the deepest areas of the basal
cell cytoplasm, immediately above (but not within) HD. The
resulting blister ¯oor is covered by the basal lamina±anchoring
®brils complex and debris of basal cytoplasm including fragments of
HD that become rapidly destroyed in early blisters. Old blisters may
therefore appear as junctional EB (``pseudojunctional'' EBS). In
unseparated perilesional and preblistering skin keratin ®laments are
unconspicuous and normal for basal cells, but their insertion into
the HD attachment plates is mostly impaired, irrespective of the site
of biopsy. Clumped basal keratins as in the Dowling±Meara type
(Anton-Lamprecht and Schnyder, 1982; Anton-Lamprecht, 1992,
1994) were never found in any of the skin samples. The HD
themselves are normally structured with regard to their extracellular
portions and have well developed subbasal dense plates and
anchoring ®laments in the lamina rara, but their intracellular
attachment plates are mostly thin and frequently separated into
small, triangular segments; their thickness is then about half of
normal HD attachment plates. Some HD may appear normal with
clear attachment and inner plates (Fig 3).
This speci®c ultrastructure is signi®cantly different from classical
cases of EBS KoÈbner, EBS Weber±Cockayne, and EBS Dowling±
Meara, which all form entirely normal HD (Haneke and Anton-
Lamprecht, 1982; Anton-Lamprecht, 1992, 1994). The aberrant
ultrastructure of HD attachment plates and their frequent frag-
mentation pointed to one of the plaque proteins, either plectin or
bullous pemphigoid antigen 1, as the primary target of the
underlying dominant mutation.
Results of immuno¯uorescence studies As shown previously,
skin samples from 10 affected members of the EBS-O family EB25,
in contrast to nine controls, consistently lacked immunoreaction of
the basal cell layer with two out of six MoAbs against rat plectin,
thus distinguishing EBS-O from controls (Koss-Harnes et al, 1997).
Figure 4. Immuno¯uorescence microscopy
of skin and muscle. Note the absence of MoAb
5B3 staining of basal keratinocytes in the skin of
German patient BED10-1 (arrows in a) whereas
staining of the healthy control is normal (b).Also
note that the staining pattern of this patient is
similar to that published earlier for EBS-O (Koss-
Harnes et al, 1997). In (c) and (d) no difference is
seen between EBS-O patient EB25-191 (c) and
the healthy control (d) upon staining of sections
with MoAb 10F6. Note normal staining of Z-line
structures in both samples. Scale bars: (a, b) 50 mm;
(c, d) 20 mm.
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The two abnormally reacting MoAbs, 10F6 and 5B3, are known to
react with epitopes in the rod domain of the molecule (Foisner et al,
1994). When skin samples from forearm and lower back of patient
BED10-1 of the German family were examined using one of these
antibodies (5B3), a lack of basal keratinocyte staining was observed,
similar to the Norwegian cases (Fig 4a).
As plectin de®ciency has serious consequences for muscle tissues,
muscle samples from ®ve members of the EB25 kindred (speci®ed
in Fig 1) and of four controls were investigated by immuno¯uor-
escence microscopy using the six different MoAbs to rat plectin.
No differences in the staining patterns of Ogna muscle versus
normal muscle were found (Fig 4b). Among the ®ve volunteer
EBS-O patients, one (EB25-66) carried HLA-B27 and had the
diagnosis of ankylosing spondylitis (Mb. Behkterev), and another
(EB25-336) had a pronounced ®bromyalgia (Fig 1). Neither of
them showed aberrant plectin staining patterns of their muscles,
however.
DISCUSSION
The relationship between clinical phenotype and genotype became
the focus of interest when detection of speci®c mutations became
available. Some clinical entities turned out to be caused by
mutations at more than one gene locus, whereas others are caused
by different mutations in one and the same gene. The lack of
reports of further EBS-O families after its ®rst description 30 y ago
(Gedde-Dahl, 1971) and its chromosomal regional assignment 15 y
ago (Olaisen and Gedde-Dahl, 1973; Astrin et al, 1982; Pocha et al,
1988) might be better understood if only very few mutations,
perhaps only the R2110W substitution, can cause this phenotype.
There are similar examples in the keratin genes: EBS with mottled
pigmentation, known from rare families, was found to be site-
speci®c for one and the same C to T mutation in codon 24 of the
keratin 5 locus in two independent families (Uttam et al, 1996) as
well as a de novo mutation in a third unrelated family (Irvine et al,
1997). In plectin the substitution of arginine with tryptophan at
codon 2110 might affect a comparably critical position causing this
particular EBS-O phenotype.
It is dif®cult to understand the lack of immunostaining of the
basal keratinocytes in dominant EBS-Ogna with antiplectin
antibodies compared to normal staining of the suprabasal
keratinocytes and of muscle tissues. Plectin is probably existing
mainly as dimers (Foisner and Wiche, 1987) so that only a quarter
of the molecules should have two normal peptides, but this does
not explain absence of antigenicity. Antibody 5B3, which does not
stain the basal layer in EBS-O, is known to bind to the rod domain
(Foisner et al, 1994). The exchange of tryptophan for arginine
within the rod domain either may prevent dimer formation or may
in¯uence the secondary folding of the polypeptide so that binding
sites even in domains other than the rod are grossly disturbed.
Plectin binding might be impaired either to the basal cell
cytokeratin subunit proteins 5 and 14, or to the hemidesmosomal
transmembrane protein integrin a6b4, both of which are known as
direct interaction partners of plectin (Nikolic et al, 1996; Rezniczek
et al, 1998; SteinboÈck et al, 2000). Binding sites for the integrin b4
subunit have been identi®ed in both the C- and N-terminal
domains of plectin, and a major intermediate ®lament binding site
has been mapped to the linker segment between repeat modules 5
and 6 in the C-terminal domain.
Previous studies have not ruled out, however, that plectin might
have more than one binding site for intermediate ®laments such as
cytokeratins. In fact it has been reported that a number of MoAbs
to plectin with rod-based epitopes interfere with the in vitro
interaction of plectin with vimentin and lamin B to different
degrees (Foisner et al, 1991).
Thus, if different binding sites exist for basal and for suprabasal
keratins, only the K5/14 binding site may be affected and disturbed
by the Ogna mutation. Another explanation for the differential
staining patterns of some antibodies in different epidermal cell
layers and in muscle could be that different oligomeric states of
plectin, such as dimers versus monomers, are required for speci®c
functions of plectin in different cells. Finally, it is equally likely that,
due to misfolding of the protein, the mutation causes a gain of
function, such as binding to a protein or structure that is normally
not occurring. This may have harmful consequences in cell types
such as basal keratinocytes, but not in others.
Recent studies on genotype±phenotype correlations on EBS
(Sùrensen et al, 1999), EB-MD (Shimizu et al, 1999), and EB
dystrophica (Bruckner-Tuderman et al, 1999) demonstrate the
complexity of these questions. Not only the position of the
mutation but also the biochemical and functional nature of the
amino acids affected by mutation and substitution contribute
considerably to the resulting phenotypical expression and anti-
genicity. In conclusion, the invariable clinical expression of the
mutation R2110W on 8q24 in all affected members of both Ogna
families from Norway and Germany, the speci®c immunoreaction
with lack of binding of antiplectin MoAb 5B3 to Ogna basal cells,
and the identical speci®c ultrastructure of defective HD and mode
of blister formation in both families underline that EBS-O is a
nosologically distinct disease among EB and the ®rst dominant
plectin disorder identi®ed.
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